3 Publisher’s Note The Lp(a): A Toolkit for Health Care Professionals is published by Ascend Media, LLC 401 SW Ward Road, Suite 210, Lee’s Summit, MO 64081 © 2024 American Heart Association, Inc., a 501(c)(3) not-for-profit. All rights reserved. Unauthorized use prohibited. All references and data are as of September 2024 Contributing Authors Marlys Koschinsky PhD, FAHA, is professor, physiology and pharmacology, and scientist at Robarts Research Institute, Schulich School of Medicine & Dentistry at Western University in Ontario, Canada. She is a recognized leader in the Lp(a) field and has unraveled many mysteries of this unique lipoprotein. She has national and international collaborations with many stakeholder groups and has helped translate knowledge from the basic biochemistry of Lp(a) to preclinical, clinical and R&D applications. Joseph L. Witztum, MD, is a Distinguished Professor of Medicine in the Division of Endocrinology and Metabolism at the University of California in San Diego. For more than 40 years, Dr. Witztum has made major contributions to the field of atherosclerosis and lipoprotein metabolism. He has been actively involved in basic and clinical studies to develop novel therapies for unmet needs, especially in the context of hypertriglyceridemia and elevated Lp(a) levels. His research has resulted in more than 500 manuscripts. Cindy Lamendola, MSN, ANP, FAHA, FPCNA, is an adult nurse practitioner and clinical research nurse manager at Stanford University School of Medicine in Stanford, California. She has focused on risk management of cardiovascular disease and type 2 diabetes. Areas of research include insulin resistance, type 2 diabetes and relationship to cardiovascular disease and lipid abnormalities, including Lpa. She is a founding member of the Preventive Cardiovascular Nurses Association, and member and fellow of AHA. Leslie L. Davis, PhD, APRN, FAAN, FAANP, FACC, FAHA, FPCNA, is an associate professor at the University of North Carolina at Chapel Hill. She also maintains a part-time nurse practitioner practice with the Division of Cardiology at the UNC Chapel Hill School of Medicine. A cardiovascular expert, Dr. Davis is a certified hypertension clinician and a fellow in the American Academy of Nursing, the American Association of Nurse Practitioners, the American College of Cardiology, the American Heart Association and the Preventive Cardiovascular Nurses Association. Disclosures Marlys Koschinsky PhD, FAHA Professional Services and Activities – Employment: University of Western Ontario Professional Services and Activities – Other Professional Activities: Amgen; Eli Lilly and Company; Novartis Joseph L. Witztum, MD Professional Services and Activities – Other Professional Activities: Ionis Financial Stake – Other Business: Oxitope, Kleanthi Diagnostic Intellectual Property – Patent: Patents and patent applications Cindy Lamendola, MSN, ANP, FAHA, FPCNA Professional Services and Activities – Employment: School of Medicine, Stanford University Professional Services and Activities – Other Professional Activities: Alnylam Pharmaceuticals, Inc.; Novo Nordisk; Novartis Pharmaceuticals Corporation; Novartis Leslie L. Davis, PhD, APRN, FAAN, FAANP, FACC, FAHA, FPCNA Professional Services and Activities – Employment: University of North Carolina at Chapel Hill Professional Services and Activities – Other Professional Activities: American Association of Nurse Practitioners; American College of Cardiology; Kentucky Association of Nurse Practitioners and Nurse Midwives; Nurse Practitioners Associates for Continuing Education; Preventive Cardiovascular Nurses Association; Skin, Bones, Hearts, and Private Parts; University of North Carolina at Chapel Hill Intellectual Property – Copyright: Journal for Nurse Practitioners Intellectual Property – Other Intellectual Property: Nursing Clinics of North America
RkJQdWJsaXNoZXIy MjI2NjI=